TY - JOUR
T1 - Functional Analysis of Induced Human Ballooned Hepatocytes in a Cell Sheet-Based Three Dimensional Model
AU - Gao, Botao
AU - Sakaguchi, Katsuhisa
AU - Ogawa, Tetsuya
AU - Kagawa, Yuki
AU - Kubo, Hirotsugu
AU - Shimizu, Tatsuya
N1 - Funding Information:
This work is supported by Adaptable and Seamless Technology Transfer Program through Target-Driven Research and Development (Grant No. JP18im0302706) from Japan Agency for Medical Research and Development (AMED), Hundred Talents Program of Guangdong Academy of Sciences (Grant No. 2020GDASYL-20200102005) and Innovation Ability Construction program of Guangdong Medical Device Research Institute (Grant No. 2017GDASCX-0103).
Publisher Copyright:
© 2021, The Korean Tissue Engineering and Regenerative Medicine Society.
PY - 2021/4
Y1 - 2021/4
N2 - BACKGROUND:: Ballooned hepatocytes (BH) are a key histological hallmark of nonalcoholic steatohepatitis (NASH), yet their consequences for liver-specific functions are unknown. METHODS:: In our previous study, an experimental model of human induced-BHs (iBH) has been successfully developed based on cell sheet technology. This study aimed to determine the functions of iBHs in the primary human hepatocyte/normal human dermal fibroblast (PHH/NHDF) co-culture cell sheets. Normal hepatocytes in the PHH/3T3-J2 co-culture cell sheets were set as a control, since 3T3-J2 murine embryonic fibroblasts have exhibited previously long term maintenance of PHH functions. RESULTS:: It was found that, albumin secretion was not affected in iBHs, but urea synthesis as well as cytochrome P450 enzyme (CYP) activities including CYP1A2 and CYP3A4, were significantly reduced in iBHs. Besides, loss of bile canaliculi was observed in iBHs. These findings are consistent with clinical studies of human NASH. In addition, PHH/NHDF cell sheets demonstrated two fold higher TGF-β1 secretion compared with PHH/3T3-J2 cell sheets. Furthermore, treatment with a TGF-β inhibitor and a semi-synthetic bile acid analogue (obeticholic acid, phase 3 trial of NASH therapy) ameliorated the histological appearance of established iBHs. CONCLUSION:: In summary, this study demonstrates the priority of iBHs in recapitulating not only histology but also clinically relevant hepatic dysfunctions in human NASH and suggests TGF-β and bile acid related signal pathway may play important roles in the formation of iBHs.
AB - BACKGROUND:: Ballooned hepatocytes (BH) are a key histological hallmark of nonalcoholic steatohepatitis (NASH), yet their consequences for liver-specific functions are unknown. METHODS:: In our previous study, an experimental model of human induced-BHs (iBH) has been successfully developed based on cell sheet technology. This study aimed to determine the functions of iBHs in the primary human hepatocyte/normal human dermal fibroblast (PHH/NHDF) co-culture cell sheets. Normal hepatocytes in the PHH/3T3-J2 co-culture cell sheets were set as a control, since 3T3-J2 murine embryonic fibroblasts have exhibited previously long term maintenance of PHH functions. RESULTS:: It was found that, albumin secretion was not affected in iBHs, but urea synthesis as well as cytochrome P450 enzyme (CYP) activities including CYP1A2 and CYP3A4, were significantly reduced in iBHs. Besides, loss of bile canaliculi was observed in iBHs. These findings are consistent with clinical studies of human NASH. In addition, PHH/NHDF cell sheets demonstrated two fold higher TGF-β1 secretion compared with PHH/3T3-J2 cell sheets. Furthermore, treatment with a TGF-β inhibitor and a semi-synthetic bile acid analogue (obeticholic acid, phase 3 trial of NASH therapy) ameliorated the histological appearance of established iBHs. CONCLUSION:: In summary, this study demonstrates the priority of iBHs in recapitulating not only histology but also clinically relevant hepatic dysfunctions in human NASH and suggests TGF-β and bile acid related signal pathway may play important roles in the formation of iBHs.
KW - Ballooned hepatocytes
KW - Cell sheet
KW - Liver function
KW - NASH
UR - http://www.scopus.com/inward/record.url?scp=85099914961&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099914961&partnerID=8YFLogxK
U2 - 10.1007/s13770-020-00297-x
DO - 10.1007/s13770-020-00297-x
M3 - Article
C2 - 33517537
AN - SCOPUS:85099914961
SN - 1738-2696
VL - 18
SP - 217
EP - 224
JO - Tissue Engineering and Regenerative Medicine
JF - Tissue Engineering and Regenerative Medicine
IS - 2
ER -